Seer (SEER) Net Equity Issued and Repurchased (2020 - 2021)

Seer (SEER) posted quarterly Net Equity Issued and Repurchased of -$636000.0 for Q2 2021, down 101.16% year-over-year from $55.0 million in Q2 2020, and down 100.61% quarter-over-quarter from $103.6 million in Q1 2021.

Seer (SEER) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

Seer's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at -$636000.0 for Q2 2021.

  • In Q2 2021, Net Equity Issued and Repurchased fell 101.16% year-over-year to -$636000.0; the TTM figure through Mar 2022 stood at -$636000.0 (down 100.4% YoY), while the FY2021 annual figure was $103.0 million, up 87.55% from the prior year.
  • Net Equity Issued and Repurchased for Q2 2021 stood at -$636000.0, down from $103.6 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $103.6 million in Q1 2021, with the low at -$55.0 million in Q3 2020.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Seer 230.63 Mn 230.63 Mn 1.51 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 -636,000.00
Jun 30, 2021 -636,000.00
Mar 31, 2021 103.60 Mn
Mar 31, 2021 103.60 Mn
Dec 31, 2020 54.90 Mn
Dec 31, 2020 54.90 Mn
Sep 30, 2020 -54.98 Mn
Sep 30, 2020 -54.98 Mn
Jun 30, 2020 54.98 Mn
Jun 30, 2020 54.98 Mn